Detalles de la búsqueda
1.
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study.
Pediatr Blood Cancer
; 61(5): 833-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24249672
2.
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.
Pediatr Blood Cancer
; 61(7): 1246-51, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24664955
3.
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Lancet Oncol
; 14(6): 472-80, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23598171
4.
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.
Pediatr Blood Cancer
; 60(9): 1452-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23554030
5.
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).
Pediatr Blood Cancer
; 60(3): 390-5, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22887890
6.
A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study.
Pediatr Blood Cancer
; 55(7): 1323-8, 2010 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20712019
7.
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.
Pediatr Blood Cancer
; 54(4): 538-45, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20049936
8.
A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.
Pediatr Blood Cancer
; 53(6): 978-83, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19637330
9.
A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.
Neuro Oncol
; 10(4): 569-76, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18497327
10.
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.
Clin Cancer Res
; 13(5): 1516-22, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17332297
11.
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.
Clin Cancer Res
; 13(6): 1789-93, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17363534
12.
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).
Clin Cancer Res
; 19(23): 6578-84, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24097866
13.
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.
J Clin Oncol
; 31(24): 3034-43, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857966
14.
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.
Cancer Chemother Pharmacol
; 69(4): 1021-7, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22179104
15.
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.
J Clin Oncol
; 30(3): 256-62, 2012 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22184397
16.
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.
Clin Cancer Res
; 18(21): 6011-22, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22962440
17.
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report.
Clin Cancer Res
; 18(18): 5081-9, 2012 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22791883
18.
A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.
Neuro Oncol
; 13(8): 910-5, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21764821
19.
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report.
Clin Cancer Res
; 17(3): 589-97, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21115653
20.
Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.
Clin Cancer Res
; 17(15): 5113-22, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21690570